Reduced D2 dopamine and muscarinic cholinergic receptor densities in caudate specimens from fluctuating parkinsonian patients
Identifieur interne : 002684 ( Main/Exploration ); précédent : 002683; suivant : 002685Reduced D2 dopamine and muscarinic cholinergic receptor densities in caudate specimens from fluctuating parkinsonian patients
Auteurs : Ahlskog ; Elliott Richelson ; Albert Nelson ; Patrick J. Kelly ; Haruo Okazaki ; Gertrude M. Tyce ; Jon A. Van Heerden ; Susan L. Stoddard [États-Unis] ; Stephen W. CarmichaelSource :
- Annals of Neurology [ 0364-5134 ] ; 1991-08.
Abstract
Binding of spiperone and 3‐quinuclidinyl benzilate (QNB), both labeled with hydrogen 3 (3H), were measured in caudate tissue obtained from 8 living parkinsonian patients at the time of cerebral transplantation. This was a clinically homogeneous group of patients: All remained predominantly responsive to levodopa, although with Marchked disability secondary to clinical fluctuations (short‐duration responses) and medication‐induced dyskinesias; all were receiving substantial doses of levodopa and 6 of the 8 patients were additionally receiving bromocriptine or pergolide. Binding densities of dopamine D2 receptors, as measured by [3H]spiperone binding, were reduced in this group of patients, compared to caudate specimens from autopsy control subjects. This finding may reflect medication‐induced receptor downregulation. Parallel changes occurred with muscarinic cholinergic receptors; [3H]QNB binding was significantly reduced, compared to autopsy control values. This reduction of muscarinic receptors might be due to loss of nigrostriatal terminals that are known to contain muscarinic receptors. Alternatively, muscarinic receptors may have been downregulated by increased corticostriatal glutamatergic input to cholinergick cells, inferred to be present based on the prominent levodopa‐induced dyskinesias. Finally, receptor deficits could have also been a reflection of more widespread degenerative cerebral disease, although levodopa‐refractory symptoms were generally not pronounced in these patients.
Url:
DOI: 10.1002/ana.410300210
Affiliations:
Links toward previous steps (curation, corpus...)
Le document en format XML
<record><TEI wicri:istexFullTextTei="biblStruct"><teiHeader><fileDesc><titleStmt><title xml:lang="en">Reduced D2 dopamine and muscarinic cholinergic receptor densities in caudate specimens from fluctuating parkinsonian patients</title><author><name sortKey="Ahlskog" sort="Ahlskog" uniqKey="Ahlskog" last="Ahlskog">Ahlskog</name></author><author><name sortKey="Richelson, Elliott" sort="Richelson, Elliott" uniqKey="Richelson E" first="Elliott" last="Richelson">Elliott Richelson</name></author><author><name sortKey="Nelson, Albert" sort="Nelson, Albert" uniqKey="Nelson A" first="Albert" last="Nelson">Albert Nelson</name></author><author><name sortKey="Kelly, Patrick J" sort="Kelly, Patrick J" uniqKey="Kelly P" first="Patrick J." last="Kelly">Patrick J. Kelly</name></author><author><name sortKey="Okazaki, Haruo" sort="Okazaki, Haruo" uniqKey="Okazaki H" first="Haruo" last="Okazaki">Haruo Okazaki</name></author><author><name sortKey="Tyce, Gertrude M" sort="Tyce, Gertrude M" uniqKey="Tyce G" first="Gertrude M." last="Tyce">Gertrude M. Tyce</name></author><author><name sortKey="Van Heerden, Jon A" sort="Van Heerden, Jon A" uniqKey="Van Heerden J" first="Jon A." last="Van Heerden">Jon A. Van Heerden</name></author><author><name sortKey="Stoddard, Susan L" sort="Stoddard, Susan L" uniqKey="Stoddard S" first="Susan L." last="Stoddard">Susan L. Stoddard</name></author><author><name sortKey="Carmichael, Stephen W" sort="Carmichael, Stephen W" uniqKey="Carmichael S" first="Stephen W." last="Carmichael">Stephen W. Carmichael</name></author></titleStmt><publicationStmt><idno type="wicri:source">ISTEX</idno><idno type="RBID">ISTEX:355CCDE4DAFB524E24E51591B2F7BD8AB09306C7</idno><date when="1991" year="1991">1991</date><idno type="doi">10.1002/ana.410300210</idno><idno type="url">https://api.istex.fr/document/355CCDE4DAFB524E24E51591B2F7BD8AB09306C7/fulltext/pdf</idno><idno type="wicri:Area/Main/Corpus">001971</idno><idno type="wicri:Area/Main/Curation">001720</idno><idno type="wicri:Area/Main/Exploration">002684</idno></publicationStmt><sourceDesc><biblStruct><analytic><title level="a" type="main" xml:lang="en">Reduced D2 dopamine and muscarinic cholinergic receptor densities in caudate specimens from fluctuating parkinsonian patients</title><author><name sortKey="Ahlskog" sort="Ahlskog" uniqKey="Ahlskog" last="Ahlskog">Ahlskog</name><affiliation><wicri:noCountry code="subField">Rochester</wicri:noCountry></affiliation></author><author><name sortKey="Richelson, Elliott" sort="Richelson, Elliott" uniqKey="Richelson E" first="Elliott" last="Richelson">Elliott Richelson</name><affiliation><wicri:noCountry code="subField">Jacksonville MN</wicri:noCountry></affiliation></author><author><name sortKey="Nelson, Albert" sort="Nelson, Albert" uniqKey="Nelson A" first="Albert" last="Nelson">Albert Nelson</name><affiliation><wicri:noCountry code="subField">Rochester</wicri:noCountry></affiliation></author><author><name sortKey="Kelly, Patrick J" sort="Kelly, Patrick J" uniqKey="Kelly P" first="Patrick J." last="Kelly">Patrick J. Kelly</name><affiliation><wicri:noCountry code="subField">Rochester</wicri:noCountry></affiliation></author><author><name sortKey="Okazaki, Haruo" sort="Okazaki, Haruo" uniqKey="Okazaki H" first="Haruo" last="Okazaki">Haruo Okazaki</name><affiliation><wicri:noCountry code="subField">Rochester</wicri:noCountry></affiliation></author><author><name sortKey="Tyce, Gertrude M" sort="Tyce, Gertrude M" uniqKey="Tyce G" first="Gertrude M." last="Tyce">Gertrude M. Tyce</name><affiliation><wicri:noCountry code="subField">Rochester</wicri:noCountry></affiliation></author><author><name sortKey="Van Heerden, Jon A" sort="Van Heerden, Jon A" uniqKey="Van Heerden J" first="Jon A." last="Van Heerden">Jon A. Van Heerden</name><affiliation><wicri:noCountry code="subField">Rochester</wicri:noCountry></affiliation></author><author><name sortKey="Stoddard, Susan L" sort="Stoddard, Susan L" uniqKey="Stoddard S" first="Susan L." last="Stoddard">Susan L. Stoddard</name><affiliation wicri:level="2"><country xml:lang="fr">États-Unis</country><placeName><region type="state">Indiana</region></placeName><wicri:cityArea>Department of Anatomy, Indiana University School of Medicine, Fort Wayne</wicri:cityArea></affiliation></author><author><name sortKey="Carmichael, Stephen W" sort="Carmichael, Stephen W" uniqKey="Carmichael S" first="Stephen W." last="Carmichael">Stephen W. Carmichael</name><affiliation><wicri:noCountry code="subField">Rochester</wicri:noCountry></affiliation></author></analytic><monogr></monogr><series><title level="j">Annals of Neurology</title><title level="j" type="sub">Official Journal of the American Neurological Association and the Child Neurology Society</title><title level="j" type="abbrev">Ann Neurol.</title><idno type="ISSN">0364-5134</idno><idno type="eISSN">1531-8249</idno><imprint><publisher>Wiley Subscription Services, Inc., A Wiley Company</publisher><pubPlace>Hoboken</pubPlace><date type="published" when="1991-08">1991-08</date><biblScope unit="volume">30</biblScope><biblScope unit="issue">2</biblScope><biblScope unit="page" from="185">185</biblScope><biblScope unit="page" to="191">191</biblScope></imprint><idno type="ISSN">0364-5134</idno></series><idno type="istex">355CCDE4DAFB524E24E51591B2F7BD8AB09306C7</idno><idno type="DOI">10.1002/ana.410300210</idno><idno type="ArticleID">ANA410300210</idno></biblStruct></sourceDesc><seriesStmt><idno type="ISSN">0364-5134</idno></seriesStmt></fileDesc><profileDesc><textClass></textClass><langUsage><language ident="en">en</language></langUsage></profileDesc></teiHeader><front><div type="abstract" xml:lang="en">Binding of spiperone and 3‐quinuclidinyl benzilate (QNB), both labeled with hydrogen 3 (3H), were measured in caudate tissue obtained from 8 living parkinsonian patients at the time of cerebral transplantation. This was a clinically homogeneous group of patients: All remained predominantly responsive to levodopa, although with Marchked disability secondary to clinical fluctuations (short‐duration responses) and medication‐induced dyskinesias; all were receiving substantial doses of levodopa and 6 of the 8 patients were additionally receiving bromocriptine or pergolide. Binding densities of dopamine D2 receptors, as measured by [3H]spiperone binding, were reduced in this group of patients, compared to caudate specimens from autopsy control subjects. This finding may reflect medication‐induced receptor downregulation. Parallel changes occurred with muscarinic cholinergic receptors; [3H]QNB binding was significantly reduced, compared to autopsy control values. This reduction of muscarinic receptors might be due to loss of nigrostriatal terminals that are known to contain muscarinic receptors. Alternatively, muscarinic receptors may have been downregulated by increased corticostriatal glutamatergic input to cholinergick cells, inferred to be present based on the prominent levodopa‐induced dyskinesias. Finally, receptor deficits could have also been a reflection of more widespread degenerative cerebral disease, although levodopa‐refractory symptoms were generally not pronounced in these patients.</div></front></TEI><affiliations><list><country><li>États-Unis</li></country><region><li>Indiana</li></region></list><tree><noCountry><name sortKey="Ahlskog" sort="Ahlskog" uniqKey="Ahlskog" last="Ahlskog">Ahlskog</name><name sortKey="Carmichael, Stephen W" sort="Carmichael, Stephen W" uniqKey="Carmichael S" first="Stephen W." last="Carmichael">Stephen W. Carmichael</name><name sortKey="Kelly, Patrick J" sort="Kelly, Patrick J" uniqKey="Kelly P" first="Patrick J." last="Kelly">Patrick J. Kelly</name><name sortKey="Nelson, Albert" sort="Nelson, Albert" uniqKey="Nelson A" first="Albert" last="Nelson">Albert Nelson</name><name sortKey="Okazaki, Haruo" sort="Okazaki, Haruo" uniqKey="Okazaki H" first="Haruo" last="Okazaki">Haruo Okazaki</name><name sortKey="Richelson, Elliott" sort="Richelson, Elliott" uniqKey="Richelson E" first="Elliott" last="Richelson">Elliott Richelson</name><name sortKey="Tyce, Gertrude M" sort="Tyce, Gertrude M" uniqKey="Tyce G" first="Gertrude M." last="Tyce">Gertrude M. Tyce</name><name sortKey="Van Heerden, Jon A" sort="Van Heerden, Jon A" uniqKey="Van Heerden J" first="Jon A." last="Van Heerden">Jon A. Van Heerden</name></noCountry><country name="États-Unis"><region name="Indiana"><name sortKey="Stoddard, Susan L" sort="Stoddard, Susan L" uniqKey="Stoddard S" first="Susan L." last="Stoddard">Susan L. Stoddard</name></region></country></tree></affiliations></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/ParkinsonV1/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 002684 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 002684 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Wicri/Sante
|area= ParkinsonV1
|flux= Main
|étape= Exploration
|type= RBID
|clé= ISTEX:355CCDE4DAFB524E24E51591B2F7BD8AB09306C7
|texte= Reduced D2 dopamine and muscarinic cholinergic receptor densities in caudate specimens from fluctuating parkinsonian patients
}}
| This area was generated with Dilib version V0.6.23. |  |